PAA 2.38% 20.5¢ pharmaust limited

The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-1108

  1. 2,861 Posts.
    lightbulb Created with Sketch. 1051
    @Captain Goodvybes

    Quite frankly I like your thinking albeit there has now been a class action activated.

    As I understand it, a RTO would normally result in PAA SHs becoming the new SH of Amylyx thus effectively listing PAA (MPL) on the US stock exchange. While this all sounds great, RTOs are normally executed with a listed company that is a shell company so its clean (tax, litigation, no operations etc) and a willing participant in the transaction.

    Unfortunately Amylyx is not fit for purpose given its not a shell company, will become a defendant in a class actin lawsuit and I am sure not a willing participant.

 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.